FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology, and can be used to predict an unfavorable response to anti-VEGF therapy in patients with macular neovascularisation. For this purpose, body weight index (BWI) is calculated before anti-VEGF therapy by Ketle formula. If its value is more than 29.1, an unfavorable response to anti-VEGF therapy is predicted.
EFFECT: invention provides a personalized approach to the indications for the anti-VEGF preparation, which increases the clinical effectiveness in the given pathology.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING AN UNFAVORABLE RESPONSE TO ANTI-VEGF THERAPY IN MACULAR NEOVASCULARIZATION BASED ON BLOOD PRESSURE PARAMETERS | 2023 |
|
RU2810940C1 |
| METHOD OF PREDICTING RESPONSE TO ANTI-VEGF THERAPY IN MACULAR NEOVASCULARIZATION | 2023 |
|
RU2810939C1 |
| METHOD OF PREDICTING UNFAVORABLE RESPONSE TO ANTI-VEGF THERAPY FOR MACULAR NEOVASCULARIZATION BASED ON INTRAOCULAR PRESSURE INDICATORS | 2023 |
|
RU2810941C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF NEOVASCULAR FORM OF AMD | 2022 |
|
RU2788103C1 |
| METHOD FOR PREDICTING RESPONSE TO REPEATED ANTI-VEGF THERAPY IN CHOROIDAL NEOVASCULARIZATION IN AMD | 2022 |
|
RU2788971C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF SUBRETINAL FIBROSIS IN PATIENTS WITH EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION GIVEN ANTI-VEGF THERAPY | 2022 |
|
RU2793419C1 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO AGE-RELATED MACULAR DEGENERATION (AMD) | 2018 |
|
RU2707955C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF MYOPIC CHOROIDAL NEOVASCULARIZATION AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN MYOPIC EYES | 2020 |
|
RU2749120C1 |
| METHOD FOR TREATMENT OF CATARACT IN PATIENTS WITH ACTIVE NEOVASCULAR DISEASES OF MACULA | 2017 |
|
RU2659144C1 |
| PHARMACEUTICAL ANTIANGIOGENIC COMPOSITION FOR TREATING EYE DISEASES | 2013 |
|
RU2526825C1 |
